AIMC Topic: Single-Domain Antibodies

Clear Filters Showing 11 to 20 of 20 articles

Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions.

mAbs
The development of bispecific antibodies that bind at least two different targets relies on bringing together multiple binding domains with different binding properties and biophysical characteristics to produce a drug-like therapeutic. These buildin...

Epitope Identification of an mGlu5 Receptor Nanobody Using Physics-Based Molecular Modeling and Deep Learning Techniques.

Journal of chemical information and modeling
The world has witnessed a revolution in therapeutics with the development of biological medicines such as antibodies and antibody fragments, notably nanobodies. These nanobodies possess unique characteristics including high specificity and modulatory...

ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins.

Communications biology
Immune receptor proteins play a key role in the immune system and have shown great promise as biotherapeutics. The structure of these proteins is critical for understanding their antigen binding properties. Here, we present ImmuneBuilder, a set of de...

NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning.

Frontiers in immunology
Antibodies are a rapidly growing class of therapeutics. Recently, single domain camelid VHH antibodies, and their recognition nanobody domain (Nb) appeared as a cost-effective highly stable alternative to full-length antibodies. There is a growing ne...

A novel nanobody and mimotope based immunoassay for rapid analysis of aflatoxin B1.

Talanta
Mimotopes could replace mycotoxins and their conjugates to develop immunoassay methods. The mimotopes obtained by phage display technology were mainly using monoclonal antibodies or polyclonal antibodies as targets. However, the mimotope of recombina...

Nanobody-based enzyme immunoassay for ochratoxin A in cereal with high resistance to matrix interference.

Talanta
A sensitive indirect competitive nanobody-based enzyme linked immunosorbent assay (Nb-ELISA) for ochratoxin A (OTA) with high resistance to cereal matrix interference was developed. Nanobodies against OTA (Nb15, Nb28, Nb32, Nb36) were expressed in E....

Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases.

mAbs
Tumor necrosis factor-alpha (TNFα) is a key pro-inflammatory cytokine implicated in the pathogenesis of numerous inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and neurodegenerative disorders such as...

NABP-LSTM-Att: Nanobody-Antigen binding prediction using bidirectional LSTM and soft attention mechanism.

Computational biology and chemistry
In vertebrates, antibody-mediated immunity is a vital component of the immune system, and antibodies have become a rapidly expanding class of therapeutic agents. Nanobodies, a distinct type of antibody, have recently emerged as a stable and cost-effe...

AI-based IsAb2.0 for antibody design.

Briefings in bioinformatics
Therapeutic antibody design has garnered widespread attention, highlighting its interdisciplinary importance. Advancements in technology emphasize the critical role of designing nanobodies and humanized antibodies in antibody engineering. However, cu...

[Construction and identification of nanobody phage display library targeting Middle East respiratory syndrome coronavirus].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Objective To construct a phage display library of specific nano-antibodies against the Middle East respiratory syndrome coronavirus (MERS-CoV) and apply it to the screening of neutralizing nano-antibodies. Methods MERS-CoV receptor-binding domain (RB...